Cushing's Disease Management: Glimpse Into 2051.
Cushings disease
circadian rhythms
digital
future
technology development
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
05
2022
accepted:
03
06
2022
entrez:
25
7
2022
pubmed:
26
7
2022
medline:
27
7
2022
Statut:
epublish
Résumé
Major advancements are expected in medicine and healthcare in the 21st century- "Digital Age", mainly due to the application of data technologies and artificial intelligence into healthcare. In this perspective article we share a short story depicting the future Cushings' Disease patient and the postulated diagnostic and management approaches. In the discussion, we explain the advances in recent times which makes this future state plausible. We postulate that endocrinology care will be completely reinvented in the Digital Age.
Identifiants
pubmed: 35872988
doi: 10.3389/fendo.2022.943993
pmc: PMC9299426
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
943993Informations de copyright
Copyright © 2022 Dalan, Bornstein and Boehm.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Sensors (Basel). 2021 Aug 19;21(16):
pubmed: 34451032
Nanomedicine (Lond). 2022 Mar 21;:
pubmed: 35311343
Horm Metab Res. 2007 Dec;39(12):908-14
pubmed: 18046661
Front Endocrinol (Lausanne). 2022 Mar 09;13:831831
pubmed: 35355570
Commun Mater. 2021;2(1):10
pubmed: 33506228
J Clin Endocrinol Metab. 1992 Sep;75(3):826-32
pubmed: 1517373
IEEE Rev Biomed Eng. 2022 Jan 11;PP:
pubmed: 35015647
Eur J Endocrinol. 2015 Oct;173(4):M133-57
pubmed: 26060052
Rev Endocr Metab Disord. 2009 Jun;10(2):103-9
pubmed: 18604646
J Neuroendocrinol. 2022 Mar 15;:e13123
pubmed: 35352410
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 1;1061-1062:438-444
pubmed: 28820982
Am J Physiol Regul Integr Comp Physiol. 2018 Jul 1;315(1):R128-R133
pubmed: 29718699
Matter. 2020 Apr 1;2(4):921-937
pubmed: 32266329
Eur J Endocrinol. 2015 Oct;173(4):M61-71
pubmed: 26282599
J Mol Med (Berl). 2021 Aug;99(8):1085-1099
pubmed: 33881561
J Neurosurg. 2002 Jul;97(1):231-4
pubmed: 12134925
Sci Adv. 2022 Jan 07;8(1):eabk0967
pubmed: 34985954
Neuroendocrinology. 2013;97(4):309-17
pubmed: 23327928
Biosens Bioelectron. 2021 Jan 15;172:112782
pubmed: 33157409
J Hypertens. 2015 Jan;33(1):44-60
pubmed: 25415766
Diabetes Technol Ther. 2018 Jun;20(6):395-402
pubmed: 29901421
Ther Drug Monit. 2014 Feb;36(1):30-4
pubmed: 24216536
Front Endocrinol (Lausanne). 2019 Jan 17;9:814
pubmed: 30705668
Ann Endocrinol (Paris). 2022 Apr;83(2):119-141
pubmed: 35192845
Rev Assoc Med Bras (1992). 2021 Nov;67(11):1687-1691
pubmed: 34909899
Clin Diabetes. 2018 Apr;36(2):203-204
pubmed: 29686463
J Clin Invest. 2011 Dec;121(12):4712-21
pubmed: 22105169
Lancet Diabetes Endocrinol. 2020 Sep;8(9):748-761
pubmed: 32730798
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8414-9
pubmed: 21536883
J Clin Endocrinol Metab. 2015 Jul;100(7):2557-64
pubmed: 25942479
NPJ Digit Med. 2021 Mar 10;4(1):45
pubmed: 33692479
Hypertension. 2019 May;73(5):e35-e66
pubmed: 30827125
J Clin Endocrinol Metab. 2019 Mar 1;104(3):925-933
pubmed: 30535260
World Neurosurg. 2022 Jun;162:126-137.e1
pubmed: 35338018
Int J Endocrinol. 2021 Dec 07;2021:3666692
pubmed: 34917145
Sci Adv. 2020 Jul 08;6(28):eabb2891
pubmed: 32923592
NPJ Digit Med. 2022 Mar 25;5(1):36
pubmed: 35338234
Sci Rep. 2020 Sep 30;10(1):16116
pubmed: 32999400
Neurosurg Focus. 2015 Feb;38(2):E11
pubmed: 25639313